Evidence map›Paper›PMID 36672242›Full record

ReviewCells2023

The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored.

Alessandro Gambella, Silvia Kalantari, Massimiliano Cadamuro, Marco Quaglia, Maurizio Delvecchio, Luca Fabris, Michele Pinon

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Alessandro GambellaDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-7826-002X
Silvia KalantariDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-9459-9741
Massimiliano CadamuroDepartment of Molecular Medicine, University of Padova, 35121 Padua, Italy.ORCID 0000-0002-0899-7613
Marco QuagliaDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0001-9423-9255
Maurizio DelvecchioMetabolic Disease and Genetics Unit, Giovanni XXIII Children's Hospital, AOU Policlinico di Bari, 70124 Bari, Italy.ORCID 0000-0002-1528-0012
Luca FabrisDepartment of Molecular Medicine, University of Padova, 35121 Padua, Italy.ORCID 0000-0001-8538-6317
Michele PinonPediatric Gastroenterology Unit, Regina Margherita Children's Hospital, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
University of Padua · ITOspedale Pediatrico Giovanni XXIII · ITOspedale Regina Margherita · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Pittsburgh · USUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hepatocyte nuclear factor 1β (HNF1B) gene is involved in the development of specialized epithelia of several organs during the early and late phases of embryogenesis, performing its function mainly by regulating the cell cycle and apoptosis pathways. The first pathogenic variant of HNF1B (namely, R177X) was reported in 1997 and is associated with the maturity-onset diabetes of the young. Since then, more than 230 different HNF1B variants have been reported, revealing a multifaceted syndrome with complex and heterogenous genetic, pathologic, and clinical profiles, mainly affecting the pediatric population. The pancreas and kidneys are the most frequently affected organs, resulting in diabetes, renal cysts, and a decrease in renal function, leading, in 2001, to the definition of HNF1B deficiency syndrome, including renal cysts and diabetes. However, several other organs and systems have since emerged as being affected by HNF1B defect, while diabetes and renal cysts are not always present. Especially, liver involvement has generally been overlooked but recently emerged as particularly relevant (mostly showing chronically elevated liver enzymes) and with a putative relation with tumor development, thus requiring a more granular analysis. Nowadays, HNF1B-associated disease has been recognized as a clinical entity with a broader and more variable multisystem phenotype, but the reasons for the phenotypic heterogeneity are still poorly understood. In this review, we aimed to describe the multifaceted nature of HNF1B deficiency in the pediatric and adult populations: we analyzed the genetic, phenotypic, and clinical features of this complex and misdiagnosed syndrome, covering the most frequent, unusual, and recently identified traits.

Indexed as

Diabetes Mellitus, Type 2Kidney Diseases, CysticChildHepatocyte Nuclear Factor 1-betaHumansKidneyPancreasHepatocyte Nuclear Factor 1-betaHNF1B protein, humancholestasiscognitive impairmenthepatopathyHNF1B deficiencykidney cystMODYnon-neoplastic conditiontumor

Identifiers

PMID36672242
PMCPMC9856658
OpenAlexW4315853278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.